Arax Advisory Partners’s Biohaven BHVN Stock Holding History

Arax Advisory Partners’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$885K	Buy	59,487 +54,547	+1,104%	+$587K	0.01%	1288
2026 Q1	$41.8K	Buy	4,940 +26	+0.5%	+$284	﹤0.01%	1758
2025 Q4	$55.5K	Buy	4,914 +4,443	+943%	+$55K	﹤0.01%	1557
2025 Q3	$7.07K	Buy	+471	New	+$6.86K	﹤0.01%	2741

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arax Advisory Partners's BHVN Position: Q2 2026 in Review

Arax Advisory Partners increased its Biohaven (BHVN) stake by 1,104% in Q2 2026, buying an estimated $587K and bringing the position to 59,487 shares worth $885K. The position accounts for 0.01% of the portfolio, ranked #1288.

Arax Advisory Partners first reported a position in BHVN in Q3 2025 and has held it in 4 quarters since. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

Arax Advisory Partners held 59,487 shares of Biohaven worth $885K as of Q2 2026.
Arax Advisory Partners bought 54,547 Biohaven shares in Q2 2026, an estimated $587K.
Biohaven made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1288 holding.
Arax Advisory Partners first reported a position in Biohaven in Q3 2025 and has held it in 4 quarters since.
292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.